Phase I (Safety) Study of Autologous Tolerogenic Dendritic Cells in Type 1 Diabetic Patients

@inproceedings{Giannoukakis2011PhaseI,
  title={Phase I (Safety) Study of Autologous Tolerogenic Dendritic Cells in Type 1 Diabetic Patients},
  author={Nick Giannoukakis and Brett Eugene Phillips and David Finegold and J. B. Harnaha and Massimo M. Trucco},
  booktitle={Diabetes care},
  year={2011}
}
OBJECTIVE The safety of dendritic cells to selectively suppress autoimmunity, especially in type 1 diabetes, has never been ascertained. We investigated the safety of autologous dendritic cells, stabilized into an immunosuppressive state, in established adult type 1 diabetic patients. RESEARCH DESIGN AND METHODS A randomized, double-blind, phase I study… CONTINUE READING